Gene · 4593
Papers3,141
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
681 to 700 of 3,141
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Single-cell transcriptomics and network pharmacology reveal therapeutic targets of Jianpi Yiqi Bugan Yishen decoction in immune cell subsets of children with myasthenia gravis. | Transl Pediatr | 2022 | 36643680 | PubTator, text mining | PubMed |
| Feature Selection Method Using Multi-Agent Reinforcement Learning Based on Guide Agents. | Sensors (Basel) | 2022 | 36616694 | PubTator, text mining | PubMed |
| Myasthenia Gravis Induced by Immune Checkpoint Inhibitors: An Emerging Neurotoxicity in Neuro-Oncology Practice: Case Series. | J Clin Med | 2022 | 36614930 | PubTator, text mining | PubMed |
| COVID-19 Vaccination and Late-Onset Myasthenia Gravis: A New Case Report and Review of the Literature. | Int J Environ Res Public Health | 2022 | 36612789 | PubTator, text mining | PubMed |
| Network-based approach for targeting human kinases commonly associated with amyotrophic lateral sclerosis and cancer. | Front Mol Neurosci | 2022 | 36590916 | PubTator, text mining | PubMed |
| Paraneoplastic Syndromes in Neuro-Ophthalmology. | Ann Indian Acad Neurol | 2022 | 36589030 | PubTator, text mining | PubMed |
| An asymptomatic giant AB thymoma in a patient with Down syndrome: a case report. | Mediastinum | 2022 | 36582979 | PubTator, text mining | PubMed |
| Bulbar onset amyotrophic lateral sclerosis: A case report. | Ann Med Surg (Lond) | 2022 | 36582871 | PubTator, text mining | PubMed |
| Myasthenia Gravis and Lambert-Eaton Myasthenic Syndrome: New Developments in Diagnosis and Treatment. | Neuropsychiatr Dis Treat | 2022 | 36578903 | PubTator, text mining | PubMed |
| Basal Cell Carcinoma and Intra-Dermal Nevus: An Addition to BCC Associated "MUSK IN A NEST". | Indian J Dermatol | 2022 | 36578746 | PubTator, text mining | PubMed |
| Sex differences in Guillain Barré syndrome, chronic inflammatory demyelinating polyradiculoneuropathy and experimental autoimmune neuritis. | Front Immunol | 2022 | 36569912 | PubTator, text mining | PubMed |
| Pneumonia in myasthenia gravis: Microbial etiology and clinical management. | Front Cell Infect Microbiol | 2022 | 36569203 | PubTator, text mining | PubMed |
| Invigorating spleen, replenishing qi and tonifying kidney method treatment of traditional Chinese medicine for myasthenia gravis: A protocol for systematic review and meta-analysis. | Medicine (Baltimore) | 2022 | 36550924 | PubTator, text mining | PubMed |
| Diagnosis and Management of Myasthenia Gravis. | Continuum (Minneap Minn) | 2022 | 36537972 | PubTator, text mining | PubMed |
| Diagnostic yield of a practical electrodiagnostic protocol discriminating between different congenital myasthenic syndromes. | Neuromuscul Disord | 2022 | 36522822 | PubTator, text mining | PubMed |
| Changing faces of mitochondrial disease: autosomal recessive POLG disease mimicking myasthenia gravis and progressive supranuclear palsy. | BMJ Neurol Open | 2022 | 36518302 | PubTator, text mining | PubMed |
| Single nuclei profiling identifies cell specific markers of skeletal muscle aging, frailty, and senescence. | Aging (Albany NY) | 2022 | 36516485 | PubTator, text mining | PubMed |
| Pembrolizumab-Induced Myasthenia Gravis and Myositis: Literature Review on Neurological Toxicities of Programmed Death Protein 1 Inhibitors. | J Med Cases | 2022 | 36506763 | PubTator, text mining | PubMed |
| Iron metabolism patterns in non-anemic patients with myasthenia gravis: A cross-sectional and follow-up study. | Front Neurol | 2022 | 36504650 | PubTator, text mining | PubMed |
| Opposite Regulation of Homer Signal at the NMJ Postsynaptic Micro Domain between Slow- and Fast-Twitch Muscles in an Experimentally Induced Autoimmune Myasthenia Gravis (EAMG) Mouse Model. | Int J Mol Sci | 2022 | 36499379 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4593/papers?page=35